ALMU 10-K & 10-Q changes, risk factors and insider trading
Aeluma, Inc. · Nasdaq · Semiconductors & Related Devices · CIK 1828805 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
New heading “Below are material factors known to us that could materially adversely affect our business, operating results, financial condition, prospects or share price. These risks are not the only risks we face, and there may be other risks, including risks not known to us or that we currently deem to be immaterial, that could materially and adversely affect our business and financial performance. Although these risks are organized by headings, and each risk is discussed separately, many are interrelated.”
New heading “Risk Factor Summary”
Removed heading “Investing in our securities includes a high degree of risk. Prior to making a decision about investing in our securities, you should consider carefully the specific factors discussed below, together with all of the other information contained in this prospectus. If any of the following risks actually occurs, our business, financial condition, results of operations and future prospects would likely be materially and adversely affected. This could cause the market price of our Common Stock to decline and could cause you to lose all or part of your investment.”
Removed heading “Risks Relating to Our Business, Growth Prospects and Operating Results”
Removed heading “We may not obtain insurance coverage to adequately cover all significant risk exposures.”
Removed heading “Our insurance coverage strategy may not be adequate to protect us from all business risks.”
Removed heading “If product liability lawsuits are brought against us, we may incur substantial liabilities.”
Removed heading “Warranty claims, product liability claims and product recalls could harm our business, results of operations and financial condition.”
Removed heading “Our business could be adversely affected by natural disasters, public health crises, political crises, economic downturns or other unexpected events.”
Removed heading “We may be subject to penny stock regulations and restrictions and if we are subject to such regulations and restrictions you may have difficulty selling shares of our Common Stock.”
Removed heading “Sales of our shares of Common Stock in the public market by investors may cause the market price of our Common Stock to decline.”
Removed heading “Our bylaws require, to the fullest extent permitted by law, that derivative actions brought in our name, actions against our directors, officers, other employees or stockholders for breach of fiduciary duty and certain other actions may be brought only in the Court of Chancery in the State of Delaware and, if brought outside of Delaware, the stockholder bringing the suit will, subject to certain exceptions, be deemed to have consented to service of process on such stockholder’s counsel, which may have the effect of discouraging lawsuits against our directors, officers, other employees or stockholders.”
Removed heading “Upon dissolution of the Company, you may not recoup all or any portion of your investment.”
Removed heading “We may face risks related to securities litigation that could result in significant legal expenses and settlement or damage awards.”
Removed heading “If we are unable to comply with the continued listing requirements of The Nasdaq Capital Market, our Common Stock could be delisted, which would adversely affect our common stock market price and liquidity and reduce our ability to raise capital.”
Largest changes
“If we are unable to comply with the continued listing requirements of The Nasdaq Capital Market, our Common Stock could be delisted, which would adversely affect our common stock market price and liquidity and reduce our ability to raise capital.”see in full comparison
“Our anticipated products and technology, including photonics and electronics based on high-performance semiconductors and technologies developed for government or regulated customers, may be subject to U.S. and foreign export controls, sanctions, import rules, and other trade restrictions. These laws and policies may require licenses or other authorizations, restrict transfers to certain countries, entities, end uses, or end users, or delay customer programs. …”see in full comparison
“Our bylaws require, to the fullest extent permitted by law, that derivative actions brought in our name, actions against our directors, officers, other employees or stockholders for breach of fiduciary duty and certain other actions may be brought only in the Court of Chancery in the State of Delaware and, if brought outside of Delaware, the stockholder bringing the suit will, subject to certain exceptions, be deemed to have consented to service of process on such stockholder’s counsel, which may have the effect of discouraging lawsuits against our directors, officers, other employees or …”see in full comparison
“We may in the future become subject to claims and litigation alleging violations of the securities laws or other related claims, which could harm our business and require us to incur significant costs. Significant litigation costs could impact our ability to comply with certain financial covenants under our credit agreement. We are generally obliged, to the extent permitted by law, to indemnify our current and former directors and officers who are named as defendants in these types of lawsuits. …”see in full comparison
“AI and AI-adjacent technologies are also subject to evolving U.S. and international regulation, procurement rules, data protection requirements, cybersecurity standards, and public scrutiny, in addition to the export control and trade restriction risks described below under “Risks Relating to the Semiconductor Industry.” These developments could increase compliance costs, restrict sales or technology transfers, delay customer programs, or reduce demand from customers in regulated industries. …”see in full comparison
“Warranty claims, product liability claims and product recalls could harm our business, results of operations and financial condition.”see in full comparison
Full comparison: every changed paragraph (99)
Below are material factors known to us that could materially adversely affect our business, operating results, financial condition, prospects or share price. These risks are not the only risks we face, and there may be other risks, including risks not known to us or that we currently deem to be immaterial, that could materially and adversely affect our business and financial performance. Although these risks are organized by headings, and each risk is discussed separately, many are interrelated.
Risk Factor Summary
This summary of risk factors is not complete and should be read in conjunction with the more complete and detailed descriptions of risks that follow.
Investing in our securities includes a high
degree of risk. Prior to making a decision about investing in our securities, you should consider carefully the specific factors discussed
below, together with all of the other information contained in this prospectus. If any of the following risks actually occurs, our business,
financial condition, results of operations and future prospects would likely be materially and adversely affected. This could cause the
market price of our Common Stock to decline and could cause you to lose all or part of your investment.
Risks Relating to Our Business, Growth Prospects
and Operating Results
Risks Relating to Our Business, Growth Prospects
and Operating Results We arehave recentlya formedlimited operating history
and onlyremain in the early
development stages. Although we have generated some revenue, we are not in volume production for any of our product
offerings. Our lack
of operating history makes it difficult to evaluate our business and prospects, and may increase the risks associated
with an investment
in our Common Stock.
BiondWe Photonics,commenced now Aeluma, was formedoperations in 2019.
Although the Company haswe
have generated some revenue, thewe Company isare subject to the risks involved with any speculative early-stage enterprise.
There is no assurance that the Company
we will successfully offer,develop, manufacture, market and distribute itsour products or services. TheWe Companyhave and may continue to experience continuing
continuing net losses and negative cash flows from operations. The extent of continuing losses and negative cash flows from operations
and the time
required to reach profitability are highly uncertain. There is no assurance that the Companywe will be able to achieve profitability
or that profitability,
if achieved, can be sustained on an ongoing basis. There is no assurance that actual cash requirements will not
exceed our estimates.
Such risks forto the Companyus include, but are not limited to:
In
order to address these risks, the Companywe must, among other things:
The CompanyWe cannot make an assurance that it will succeed
succeed in addressing these risks.
We have entered into a letter of intent with the U.S. Department of Commerce for proposed funding under the CHIPS and Science Act, which remains subject to execution of definitive award documents and may result in substantial restrictions on our business and operations.
We cannot be certain whether we and the U.S. Department of Commerce will establish an execute definitive award documents for the proposed funding on acceptable terms, or at all. Even then, the award will be tied to eligible project costs, and a portion of the award is expected to be funded on a milestone-based award structure tied to technical progress, resulting in uncertainty as to whether, when, and in what amounts we may receive or retain any portion of the proposed funding.
The perceived and actual dilutive effective of the proposed issuance of common stock to the U.S. Department of Commerce pursuant to the award could adversely affect market perception or the price of our common stock. Reputational, regulatory, or governance considerations that may accompany a government investment in our Company could impose substantial restrictions on our business and operations and could also adversely affect future opportunities.
It is also possible that the anticipated benefits of the proposed funding, including acceleration of commercialization and scaling of our non-InP photonics platform, may not be realized on the timeline anticipated or at all. Further, changes in U.S. government policy, funding priorities, or budgetary constraints could affect the availability or continuation of CHIPS and Science Act programs, both before and after definitive award documents have been established.
Historically, we have funded our operations and
and capital expenditures primarily through equity issuances and cash generated from our operations. Although we currently anticipate that
that our existing cash and cash equivalents and cash flow from operations will be sufficient to meet our cash needs for the
foreseeable future,
our business may not always generate sufficient cash flow from operations to fund our activities and we may
require additional financing,
which we may not be able to obtain on favorable terms. If we raise equity financing to fund operations
or on an opportunistic basis, our
stockholders may experience significant dilution of their ownership interests. If we engage in
debt financing, we may be required to accept
terms that restrict our ability to incur additional indebtedness, force us to maintain
specified liquidity or other ratios or restrict
our ability to pay dividends or make acquisitions. Additionally, if we need such
financing and it is not available to us, or is not available
to us on satisfactory terms, our ability to operate and expand our
business or to respond to competitive pressures would be limitedlimited, and
we could be required to delay, significantly curtail, or
eliminate planned operations or other elements of our growth strategy. To reduce this risk, Although
we filedhave thea Shelf S3, which allows us
to sell any combination of the securities described in theshelf registration statement on file and an at-the-market offering in one or more offerings up to a total dollar
amount of proceeds of $100,000,000; however,place, there is no guarantee that we will sell any sharesadditional
shares, pursuantthat market conditions will be favorable for such sales, or that proceeds of any offering will be sufficient to thefund Shelfour S3.capital
requirements.
There can be no assurance that we can successfully
achieve any or all of the above initiatives in the manner or time period that we expect. Further, achieving these objectives will require
investments that may result in short-term costs without generating any current revenue and therefore may be dilutive to our earnings.
We cannot provide any assurance that we will realize, in full or in part, the anticipated benefits we expect our strategy will achieve.
The failure to realize those benefits could have a material adverse effect on our business, financial conditioncondition, and results of operations.
Market opportunity estimates and forecasts regarding our target markets may prove inaccurate and should not be viewed as indicative of our future revenue or growth.
We rely on third-party market research and internal assumptions to evaluate opportunities in mobile and consumer electronics, automotive lidar, AI, silicon photonics, quantum computing, and other markets. These estimates are inherently uncertain and may prove inaccurate. Even if these markets grow as expected, we may not develop products that address them, win customers in those markets, or achieve meaningful revenue, and investors should not rely on market-size estimates or addressable-market estimates as an indication of our future revenue or growth.
Changes to federal regulatory agencies
and policies, including the Department of Commerce, could poseadversely risks related
toaffect our business operations and financial outlook.
The Department of Commerce is particularly relevant to our industry because it administers programs and policies affecting the semiconductor industry, including the CHIPS Program. Changes in the administration, funding, eligibility requirements, implementation, or priorities of these programs, as well as changes to other Commerce Department policies, including those relating to semiconductor trade and export controls, could affect our access to government programs, incentives, approvals, or other resources and could increase regulatory uncertainty or compliance costs. Any such changes, delays, or disruptions could adversely affect our ability to execute our business plans and could materially adversely affect our business, financial condition, and results of operations.
Our future success is substantially dependent
on our ability to attract, retainretain, and motivate the members of our management team and other key employees throughout our organization.organization,
including in technical, engineering, sales, and operational roles. The loss of one or more members of our management team or other key
employees could materially impact our sales or our R&D programs
and materially harm our business, financial condition, results of operations
operations, and prospects. We do not maintain key person life insurance
policies on any of our management team members or key employees.
Competition for highly skilled personnel in the semiconductor and photonics industries is intense.intense, particularly for candidates with expertise
in compound semiconductors, heterogeneous integration, and related technologies. We may not be successful
in attracting or retaining qualified
personnel to fulfill our current or future needs. For positions in our offices near Santa Barbara
in particular, we may experience challenges
hiring new and mid-level employeesemployees, in part due to the high local housing costs.costs and cost of living. Our competitors
may be successful
in recruiting and hiring members of our management team or other key employees, and it may be difficult for us to find
suitable replacements
on a timely basis, on competitive terms, or at all.
Accounting methods and policies for companies
such as ours, including policies governing revenue recognition, leases, R&D and related expenses, and accounting for stock-based compensation,
are subject to review, interpretation and guidance from our auditors and relevant accounting authorities, including the SEC. Changes to
accounting methods or policies, or interpretations thereof, may require us to reclassify, restate or otherwise change or revise our historical
financial statements, including those contained in this prospectus.report.
We willexpect to depend on a limited
number of customers
and the loss of one or more of these customers could have a material adverse effect on our business, financial condition,
and results
of operations.
Currently, Aeluma has customer engagements that
involve R&D, development of wafers, and delivery of engineering samples for evaluation.evaluation, delivery of small volumes of chips, and R&D
contracts. There is no assurance that any of these potential
customers will purchase our product after they complete their analysis.analysis, or
that any customer engagement, engineering sample, evaluation, NRE effort, or development project will result in a design win, binding
purchase order, volume production, or recurring revenue. Since we cannot predict how many of these evaluations will turn
into sales, if
any, we cannot guarantee that we will generate sufficient revenue to be profitable.
Due to the concentration and ongoing consolidation
within the semiconductor industry, we may also find that over the longer term, our revenues are dependent on relatively few customers.
If we lose any of these customers, or these customers dodelay, notdispute or fail to pay us,us or experience budgetary, liquidity, administrative
or other constraints that impair our ability to collect accounts receivable, our revenues and cash flows could be materially adversely
affected.
We expect that our sales will be typically made
pursuant to individual purchase orders or customer agreements, and we do not expect to have long-term supply arrangements with our customers
requiring a commitment to purchase. We expect that the agreements with our customers may allow them to cancel orders prior to shipment
for standard products and, generallygenerally, prior to start of production for custom products without incurring a penalty. We anticipate to routinely
generategenerating inventory based on customers’ estimates of end-user demand for their products, which is difficult to predict. In times
of under supplyundersupply for certain products, some customers could respond by inflating their demand signals. As markets level off and supply capacity
capacity begins to match actual market demands, we could experience an increased risk of inventory write-downs, which may materially adversely
affect our results of operations and our financial condition. In addition, our customers may change their inventory practices on short
notice for any reason. Furthermore, short customer lead times are standard in the industry due to overcapacity. The cancellation or deferral
of product orders, the return of previously sold products, or overproduction of products due to the failure of anticipated orders to materialize
could result in excess obsolete inventory, which could result in write-downs of inventory or the incurrence of significant cancellation
penalties under our arrangements with our raw materials and equipment suppliers. Unsold inventory, canceled orders, and cancellation penalties
may materially adversely affect our results of operations, and inventory write-downs, which may materially adversely affect our financial
condition.
Prior to purchasing our products, our customers
may require that our products undergo an extensive qualification process, which involves testing of the products in the customer’s
system, as well as rigorous reliability testing. This qualification process may continue for a few months or longer, may require us to
provide wafers, chips, engineering samples, NRE services, or other support, and we cannot guarantee
that products will pass the required
tests. tests.Customer selection or a “design win,” if any, does not obligate a customer to place purchase orders or to proceed to
volume production. However, qualification of a product by a customer does not ensure any sales of the product
to that customer. Even after
successful qualification and sales of a product to a customer, a subsequent revision to the product or software,
changes in the product’s
manufacturing process or the selection of a new supplier by us may require a new qualification process,
which may result in delays and
in us holding excess or obsolete inventory. After our products are qualified, additional time may be required
before the customer commences
volume production of components or devices that incorporate our products. Despite these uncertainties, we
will devote substantial resources,
including design, engineering, sales, marketing and management efforts, toward qualifying our products
with customers in anticipation
of sales. If we are unsuccessful or delayed in qualifying any of our products with a customer, such failure
or delay would preclude or
delay sales of such product to the customer, which may impede our growth and cause our business to suffer.
While we believe that we have implemented adequate
security measures within our internal information technology and networking systems, our information technology systems may be subject
to security breaches, damages from computer viruses, ransomware, phishing attacks, natural disasters, terrorism, power outages, and telecommunication
failures. failures.The semiconductor industry has been, and may continue to be, the target of cyber attacks, including those aimed at obtaining
intellectual property, disrupting manufacturing processes, or compromising confidential business information. Any system failure
or security
breach could cause interruptions in our operations in addition to the possibility of losing proprietary informationinformation, trade secrets, or
sensitive customer and trade
secrets.partner data. To the extent that any disruption or security breach results in inappropriate disclosure of our confidential
information, our
competitive position may be adversely affected, and we may incur liabilityliability, regulatory penalties, or additional costs
to remedy the damages caused by these disruptions
or security breaches. We may also be required to expend significant resources to protect
against, respond to, and recover from any such attacks or disruptions.
We conduct certain R&D activities and production
of our products at external partner facilities, which has the potential to expose third parties to elements of our intellectual property.
We rely primarily on a combination of nondisclosure agreements and
other contractual provisions,provisions and patent, trade secret and copyright
laws to protect our technology and intellectual property. If we fail
to protect our technology and intellectual property, our customers,
licensees, and others may seek to use our technology and intellectual
property without the payment of license fees and royalties, which
could weaken our competitive position, reduce our operating results
and increase the likelihood of costly litigation. The growth of our
business depends in large part on our ability to secure intellectual
property rights in a timely manner, our ability to convince third
parties of the applicability of our intellectual property rights, and
our ability to enforce our intellectual property rights. In certain
instances, we attempt to obtain patent protection for portions of
our technology, and our agreements may include both issued patents and
pending patent applications. If we fail to obtain patents in a
timely manner or if the patents issued to us do not cover all of the inventions
disclosed in our patent applications, others could use
portions of our technology and intellectual property without the payment of license
fees and royalties.
Further, the laws and enforcement regimes of
certain certain
countries do not protect our technology and intellectual property to the same extent as do the laws and enforcement regimes of
the U.S.
In certain jurisdictionsjurisdictions, we may be unable to protect our technology and intellectual property adequately against unauthorized
use, which
could adversely affect our business.
If the Companywe cannot effectively manage growth
growth by implementing and improving its operational and financial systems, the Company’sour business, prospects, financial condition,
and results of operations
could be materially adversely affected.
In order to maximize the potential growth in the
Company’sour market opportunities, the Companywe may have to expand rapidly and significantly. The impetus for expansion could place
a significant strain
on theour management, operational and financial resources of the Company.resources. In order to manage growth, the Companywe will
be required to implement and continually improve its
our operational and financial systems, expand operations, attract and retain superior
management and train, manage and expand itsour employee
base. The CompanyWe can give no assurance that itwe will effectively manage itsour operations,
that itsour system, procedures, or controls will adequately
support operations or that our management of the Company will successfully implement
its our business plan. If the Companywe cannot effectively manage growth, the Company’sour business,
prospects, financial condition and results
of operations could be materially adversely affected.
Product liability lawsuits, warranty claims, and product recalls could result in substantial liabilities and harm our business, results of operations, and financial condition.
We may not obtain insurance coverage to
adequately cover all significant risk exposures.
We will be exposed to liabilities that are unique
to the products and services we provide. There can be no assurance that we will acquire or maintain insurance for certain risks, that
the amount of our insurance coverage will be adequate to cover all claims or liabilities, or that we will not be forced to bear substantial
costs resulting from risks and uncertainties of business. It also may not be possible to obtain insurance to protect against all operational
risks and liabilities. The failure to obtain adequate insurance coverage on terms favorable to us, or at all, could have a material adverse
effect on our business, financial condition, and results of operations.
Our insurance coverage strategy may not
be adequate to protect us from all business risks.
We may be subject, in the ordinary course of business,
to losses resulting from product liability, accidents, acts of God and other claims against us, for which we may have inadequate insurance
coverage. Our insurance policies may include significant deductibles or self-insured retentions, policy limitations and exclusions, and
we cannot be certain that our insurance coverage will be sufficient to cover all future losses or claims against us. A loss that is uninsured
or that exceeds applicable coverage limits may require us to pay substantial amounts, which may harm our financial condition and operating
results.
If product liability lawsuits are brought
against us, we may incur substantial liabilities.
Warranty claims, product liability claims
and product recalls could harm our business, results of operations and financial condition.
Manufacturing semiconductors is a highly complex
and precise process, requiring production in a tightly controlled, clean environment. Minute impurities in our manufacturing materials,
contaminants in the manufacturing environment, manufacturing equipment failures, and other defects can cause our products to be non-compliant
with customer requirements or otherwise nonfunctional.nonfunctional, Weexposing face an inherent business risk of exposureus to warranty and product liability
claims in the event that our products
fail to perform as expected or such failure of our products results isare alleged to result in bodily
injury or property damage (or both).damage. In addition, if any of our designed products
are or are alleged to be defective, we may be required
to participate in their recall. A successful warranty or product liability claim
against us in excess of our available insurance coverage,
if any, and established reserves, or a requirement that we participate in a
product recall, could have material adverse effects on our
business, results of operations and financial condition. Additionally, in the event thatdamage our products fail to perform as expected or such
failure of our products results in a recall, our reputation may be damaged, which couldreputation, make it more difficult for us to sell our products
to existing and prospective customers customers,
and couldhave materiallymaterial adverselyadverse affecteffects on our business, results of operationsoperations, and financial condition.
Natural disastersdisasters, andpublic health
crises, political crises, economic downturns, or other businessunexpected disruptions
events could cause significant harm to our business operations and facilities and could facilities,
adversely affect our supply chain and our customer base,
any of which mayand materially adversely affect our business, results of operation,operations and financial condition.
We expect that our manufacturing and other facilities,
asour welloperations, asand the operations of our third-party suppliers,suppliers and technology providers are susceptible to losses and interruptions caused
by floods, fires, hurricanes,
tornadoes, earthquakes, typhoons, and similar natural disasters, as well as power outages, telecommunications
failures, industrial accidents, pandemics,
terrorist attacks, war and other political instability, and similar events.events, whether in mainland
China or abroad. The occurrence of naturalany disasterssuch event in any of the regions in which wewe, our suppliers, or our supplierstechnology willproviders operate
could severely
disrupt theour operations ofand ourdaily businessesbusiness activities by negatively impacting our supply chain, our ability to deliver products,
and the cost of our
products. products, and could adversely affect the economies of the markets in which we operate. Such events can negatively
impact revenue and earnings and can significantly impact cash flow, both from decreased revenue and
from increased costs associated with
the event.event, In addition, these eventsand could cause consumer confidence and spending to decrease. All of the aforementioned risks may be further increased if our
disaster recovery plans prove to be inadequate. We
may carry insurance to generally compensate for losses of the type noted above, however,
even if we obtain such insurance, it may not
be adequate to cover all losses that may be incurred or continue to be available in the affected
area at commercially reasonable rates
and terms. Disruptions or downturns in global, national, or local economic conditions may also cause
demand for our products and services to decline, and an economic downturn resulting in a prolonged recessionary period would have a material
adverse effect on our business, financial condition, and operating results. To the extent any losses from natural disastersdisasters, public health
crises, political crises, or other business disruptions are not covered by insurance, any costs, write-downs,
impairments, and decreased
revenue can materially adversely affect our business, our results of operations and our financial condition.
ThereWe ismay nobe assuranceunable onto thecomplete futureor successfulsuccessfully
completion ofintegrate strategic transactionstransactions, bywhich uscould limit our ability to successfully implementexecute our business strategies.
Our business strategies may depend on our ability
to toidentify and complete futurestrategic transactions, including acquisitions, investments, joint ventures, and strategic transactions
could be important to the successful implementation of our business strategies, including our strategiespartnerships, to strengthen
our geographic
diversity and broaden itsour customer base. We may be unable to identify suitable opportunities, reach acceptable terms, obtain
required approvals or financing, or successfully integrate completed transactions. Any such failure could limit our ability to execute
our business strategies and materially adversely affect our business, results of operations, and financial condition. Successful completion
of a strategic manufacturing partnership agreement or other similar transaction
depends on a number of factors that are not entirely within
our control, including our ability to negotiate acceptable terms, conclude
satisfactory agreements and obtain all necessary regulatory
approvals. In seeking to partner with another company, we may require capital
investment, funding for operations, or dedicated personnel
with special skills. If we need to finance this activity, we may not be able
to obtain the necessary financing on satisfactory terms and
within the timeframe that would permit the transaction to proceed. If any
of these factors prevent us from completing one or more strategic
transactions, we may not be able to expand our business in the manner
and on the schedule that we plan. In addition, we may incur significant
costs arising from our efforts to engage in strategic transactions.
These costs may exceed the returns that we realize from a given transaction.
Moreover, these expenditures may not result in the successful
completion of a transaction.
Our business could be adversely affected
by natural disasters, public health crises, political crises, economic downturns or other unexpected events.
A significant natural disaster, such as an earthquake,
fire, hurricane, tornado, flood, or significant power outage, could disrupt our operations, mobile networks, the internet or the operations
of our third-party technology providers. In addition, any further outbreaks of COVID-19 or other unforeseen public health crises,
or political crises, such as terrorist attacks, war and other political instability, or other catastrophic events, whether in mainland
China or abroad, could adversely affect our operations or the economies of the markets where we operate. The COVID-19 pandemic adversely
affected the semiconductor industry between 2020 and 2021, and we cannot assure you that new outbreaks, particularly with new variants,
will not occur. Any such occurrences could cause severe disruption to our daily operations. Any natural disaster, act of terrorism or
other disruption to us or our business partners’ abilities could result in decreased demand for our product and service offerings
or a delay in the provision of our offerings, which could adversely affect our business, financial condition, and results of operations.
All of the aforementioned risks may be further increased if our disaster recovery plans prove to be inadequate. Disruptions or downturns
in global or national or local economic conditions may cause demand for our products and services to decline. An economic downturn resulting
in a prolonged recessionary period would have a material adverse effect on our business, financial condition, and operating results.
Our officers and directors are not required to,
and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between
our operations
and their other occupations. Our officers may be engaged in other business endeavors for which they may be entitled to
substantial compensation compensation,
and our officers are not obligated to contribute any specific number of hours per week to our affairs. Our directors
also serve or may
serve as officers or board members for other entities. If our officers’ or directors’ other business affairs
require them
to devote substantial amounts of time to such affairs in excess of their current commitment levels, it could limit their
ability to devote
time to our affairs, which may have a negative impact on our ability to carry out our operations and goals. For a complete
discussion of our officers’ and directors’ other business affairs, please see the section of this prospectus entitled “Management.”
Dependence on customers in regulated industries and changes in applicable laws and regulations could adversely affect demand for our products and business.
Our business prospects depend, in part, on the demand for our products from customers operating in industries that are or may be subject to evolving federal, state, local and foreign laws and regulations. Changes in, or the interpretation, implementation or enforcement of, such laws and regulations, including those relating to environmental protection, trade policy, export controls, data privacy, taxation, or industry-specific compliance requirements, may increase our customers’ costs of doing business, restrict their operations, delay or cancel their capital expenditure plans, or otherwise adversely affect their financial condition.
Demand for our technologies may not develop as we expect, and evolving regulation and competition could adversely affect our business, financial condition, and results of operations.
Our technology may be used in applications involving AI, high-performance computing, sensing, communications, defense and aerospace, mobile devices, and quantum computing. Although we believe our heterogeneous integration platform, photodetectors, photodetector arrays, quantum dot lasers, and other photonic and electronic semiconductor technologies may be relevant to AI-related applications, we are an early-stage company, we have not achieved volume production for any product offering, and growth in AI-related markets may not result in meaningful demand for our specific technologies or products. AI infrastructure investment cycles may be volatile and may be affected by customer capital expenditure decisions, changing technical architectures, energy and cost constraints, supply chain limitations, and shifts in customer priorities. If customers adopt competing technologies, develop solutions internally, reduce AI-related investments, or determine that our products do not meet their performance, cost, reliability, qualification, or integration requirements, our ability to commercialize our products and grow revenue could be materially and adversely affected.
AI and AI-adjacent technologies are also subject to evolving U.S. and international regulation, procurement rules, data protection requirements, cybersecurity standards, and public scrutiny, in addition to the export control and trade restriction risks described below under “Risks Relating to the Semiconductor Industry.” These developments could increase compliance costs, restrict sales or technology transfers, delay customer programs, or reduce demand from customers in regulated industries. In addition, larger semiconductor, photonics, foundry, systems, and technology companies may have greater resources, manufacturing access, customer relationships, and product roadmaps for AI-related markets than we do. If we are unable to compete effectively, or if products incorporating our technologies are associated with AI-related applications that are perceived as unsafe, unreliable, controversial, or inconsistent with evolving legal, ethical, or social expectations, our reputation, customer relationships, business, financial condition, and results of operations could be materially and adversely affected.
We expect to subcontract wafer fabrication services
to third-party
suppliers. suppliers, including foundries. These suppliers also offer such services to other companies, whichand we expect to be a relatively
small customer compared to larger semiconductor companies. As a result, we may lead to us not havinghave access to adequate capacity for
our needs and
our customers’ needs.needs, Weand we may have less control over delivery schedulesschedules, pricing, and overall support versusthan otherlarger customers of
andthose usersfacilities. Additionally, certain foundry processes critical to our products may only be available from a limited number of thosesuppliers,
creating facilities.concentration risk. If the wafer foundries we use are unable or unwilling to manufacture our products in our required volumes,
or at specified times, we may have to identify and qualify acceptable additional or alternative foundries. This qualification process
could require significant time and capital, and we may not find sufficient capacity in a timely manner or at an acceptable cost to satisfy
our production requirements.
Because we willexpect to depend on third-party
manufacturers manufacturers
to build portions of our products, we will be susceptible to manufacturing delays and pricing fluctuations that could prevent
us from
shipping customer orders on time, if at all, or on a cost-effective basis, which may result in the loss of sales, income, and
customers.
Our manufacturing processes will rely on many
raw materials.materials, components, equipment, logistics providers, and third-party suppliers, including specialty materials such as indium, gallium,
arsenic, and others that are essential to III-V compound semiconductor manufacturing. Generally,
we expect that our agreements with suppliers
of raw materials will impose no minimum or continuing supply obligations, and we will obtain
our raw materials and supplies from a large
number of sources on a just-in-time basis. From time to time, suppliers of raw materials may
extend lead times, limit supplies, or increase
prices due to capacity constraints or other factors beyond our control. Shortages could
occur in various essential raw materials due to
interruptions interruptionin ofsupply, supplyincreased demand, or increasedgeopolitical demand.factors. If we are unable to obtain adequate supplies
of raw materials in a
timely manner, the costs of our raw materials increase significantly, their quality deteriorates or they give rise
to compatibility or
performance issues in our products, our results of operations could be materially adversely affected. Geopolitical conflicts, trade restrictions,
conflictsand export controls might unfavorably impact the availability of rare earths or rare minerals such as indium, gallium, arsenic, etc.,
which are
used in our manufacturing processes or in the manufacturing of other components in our customers’ systems. China is a
significant global supplier of certain critical raw materials and minerals, including materials important to the semiconductor industry,
and any restrictions on exports from China or other key supplier countries, or retaliatory actions by those countries, could materially
impact our supply chain and increase our costs. If any country or entity
decided to reduce or ration the volumes available to us, our
supplier eco-system or our customers’ supply-chains,supply chains, our business could
be materially adversely impacted.
Export controls, sanctions, and other trade restrictions applicable to semiconductor, photonics, defense, aerospace, AI, and quantum technologies could limit our ability to sell or transfer our products and technology.
Our anticipated products and technology, including photonics and electronics based on high-performance semiconductors and technologies developed for government or regulated customers, may be subject to U.S. and foreign export controls, sanctions, import rules, and other trade restrictions. These laws and policies may require licenses or other authorizations, restrict transfers to certain countries, entities, end uses, or end users, or delay customer programs. Changes in export control or sanctions policies, including restrictions involving advanced semiconductors, AI, quantum, defense, aerospace, communications, or related technologies, could prevent or delay the sale, shipment, transfer, or use of our products or technology, increase compliance costs, or expose us to penalties, investigations, reputational harm, or loss of export privileges if we fail to comply.
Our inability to compete effectively could materially
adversely affect our business and results of operations. Products or technologies developed by competitors that are larger and have more
substantial R&D budgets, or that are smaller and more targeted in their development efforts, may render our products or technologies
obsolete or noncompetitive. We also may be unable to market and sell our products if they are not competitive on the basis of price, quality,
technical performance, features, system compatibility, customized design, innovation, availability, delivery timing and reliability. If
we fail to compete effectively onin developing strategic relationships with customers and customer sales and technical support, our sales
and revenue may be materially adversely affected. Competitive pressures may limit our ability to raise prices, and any inability to maintain
revenue or raise prices to offset increases in costs could have a significant adverse effect on our gross margin. Reduced sales and lower
gross margins would materially adversely affect our business and results of operations.
The semiconductor industry is characterized by
the high costs associated with developing marketable products and manufacturing technologies as well as high levels of investment in production
capabilities. As a result, the semiconductor industry has experienced, and may continue to experience, significant consolidation among
companies and vertical integration among customers. Larger competitors resulting from consolidations may have certain advantages over
us, including, but not limited to substantially greater financial and other resources with which to withstand adverse economic or market
conditions and pursue development, engineering, manufacturing, marketing, andor distribution of their products; longer independent operating
histories; presence in key markets; patent protection; and greater name recognition. In addition, we may be at a competitive disadvantage
to our peers if we fail to identify attractive opportunities to acquire companies to expand our business. Consolidation among our competitors
and integration among our customers could erode our market share, negatively impact our capacity to compete and require us to restructure
our operations, any of which would have a material adverse effect on our business.
We plan to use third-party contractors for certain of our manufacturing activities. Our agreements with these manufacturers may require us to commit to purchase services based on forecasted product needs, which may be inaccurate, and, in some cases, require longer-term commitments. We will also be dependent upon a limited number of highly specialized third-party suppliers for required components and materials for certain of our key technologies. Arranging for replacement manufacturers and suppliers can be time-consuming and costly, and the number of qualified alternative providers can be extremely limited. In addition, our foundry, packaging, integration, and other ecosystem partners may not prioritize our programs, maintain capacity for our needs, align with our technology roadmap, or meet the quality, timing, cost, or process requirements needed to scale our products. Our business operations, productivity and customer relations could be materially adversely affected if these contractual relationships were disrupted or terminated, the cost of such services increased significantly, the quality of the services provided deteriorated, or our forecasted needs proved to be materially incorrect.
Special authorizations, permits, and licenses may be required for our operations, which if delayed or denied could materially adversely affect our results of operations and financial condition.
Management's Discussion & Analysis (MD&A)
New heading “Recent Government Customer Contracts”
Removed heading “Recent Government Contracts”
Removed heading “Private Placements and Conversion of Notes”
Removed heading “Public Offering of Common Stock”
Removed heading “Executive Officer Announcements”
Removed heading “Plan of Operations”
Removed heading “Limited Operating History”
Removed heading “Results of Operations”
Removed heading “Recent Accounting Pronouncements”
Largest changes
see in full comparisonFollowingWethehaveOffering,raisedmanagementapproximatelyhas$60assessedmillion throughourpublicfinancialofferingspositionfrom March 2025 to date. We have also established an at-the-market offering program to sell up to $50 million of common stock, pursuant to which we have $29.3 million in remaining capacity. The proceeds of these offerings have been used primarily to fund R&D efforts, expand engineering capabilities, andoperatingsupportplangeneralandcorporatedetermined that the previously reported substantial doubt about our ability to continue as a going concern has been alleviated.operations. The proceeds from theOfferingcompleted offerings have provided near-term capital to support our operations and ongoing development efforts. However, we continue to face risks typical ofearly-stagedevelopmentcompanies,stageincludingcompanies including, but not limitedcapital resources,to, operational and financial challenges,anduncertainty in productdevelopment.development, and product-market fit.
Prior to thesee in full comparisonOffering,public offerings, our operations were primarily financed through the issuance of convertible notes and sales of common stock in private placement transactions.AsWepreviously disclosed,intendwe had expressed substantial doubt about our abilityto continueastoausegoingtheconcernnetdueproceeds from the offerings torecurringsupportlossesoperational growth, invest in product development, andnegativefundoperatingworking capitalcash flows.andWithgeneralthecorporatesuccessful completion of the Offering, we believe that substantial doubt about our ability to continue as a going concern has been alleviated for at least the next twelve months.purposes.
“Between August 5, 2024 and August 27, 2024, we issued convertible promissory notes in the aggregate principal amount of $3.1 million to 10 accredited investors, pursuant to a private note financing. The Notes were to mature in June 2026 and did not carry any interest. …”see in full comparison
As of June 30,see in full comparison2025,2026, we had net workingcapitalcapital, defined as total current assets less total current liabilities, of$16.6$55.4 million, compared to$766$16.6thousandmillionas ofat June 30,2024.2025. The increase was primarily driven by a$15.9$40.0 million increase in current assets, which rose to$17.3$57.3 million from$1.4$17.3 million over the same period, largely due to a$14.4$40.3 million increase incash,cash and cash equivalents,andincludingathe certificate of deposit balance at June 30, 2025.deposit.Current liabilities totaled$706$1.9thousandmillion and$627$705 thousand as of June 30,20252026 and2024,2025, respectively, and the balances primarily consistedconsistedof accounts payable, along with accrued expenses and other short-term obligations expected to be settled within one year. We believe that our current cash and cash equivalents balances, cash generated from operations and our ability to raise additional funds pursuant to the ATM program will be sufficient to fund our business operations and capital expenditures for the next twelve months and beyond.
Full comparison: every changed paragraph (69)
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our financial statements and the accompanying notes included elsewhere in this Annual Report on Form 10-K. The forward-looking statements include statements that reflect management’s good faith beliefs, plans, objectives, goals, expectations, anticipations and intentions with respect to our future development plans, capital resources and requirements, results of operations, and future business performance. Our actual results could differ materially from those anticipated in the forward-looking statements included in this discussion as a result of certain factors, including those identified in Part I, Item 1A, of this report.
Unless otherwise stated or the context otherwise
indicates, references to “Aeluma,” the “Company,” “we,” “our,” “us,” or similar
terms refer to Aeluma, Inc. and Subsidiary.
You should read the following discussion and analysis
of our financial condition and results of operations, together with our consolidated financial statements and the related notes and other
financial information included in this report. Some of the information contained in this discussion and analysis or set forth elsewhere
in this report, including information with respect to our plans and strategy for our business, includes forward-looking statements that
involve risks and uncertainties. You should review the disclosure under the heading “Risk Factors” in other filings we make
with the SEC for a discussion of important factors that could cause actual results to differ materially from the results described in
or implied by the forward-looking statements contained in the following discussion and analysis. You should not place undue reliance on
forward-looking statements as predictive of future results.
Our business commenced operations in 2021 and our operations remain in the development stage. To date, our activities have been primarily concentrated on product design, engineering validation, prototyping, and establishing manufacturing and supply chain relationships. We have not yet generated significant revenues from commercial product sales and continue to devote substantial resources to R&D, product qualification, and market readiness.
Aeluma develops novel optoelectronic and electronic devices for sensing,
communication, and computing applications. Aeluma has pioneered a technique to produce semiconductor materials and chips using high-performance
compound semiconductors on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. This enables
cost-effective manufacturing of high-performance photodetectors and photodetector arrays for imaging applications in mobile devices, as
well as other applications. Aeluma’s technology has the potential to impact a broad range of market verticals. Aeluma is based in
Goleta, California, where we operate in a 9,000 sq. ft. facility with a state-of-the-art R&D/manufacturing cleanroom and access to
world-class rapid prototyping capabilities. The facility houses unique equipment for scalable manufacturing. Aeluma also partners with
production-scale fabrication foundries and packaging companies. Aeluma maintains extensive patent protection and trade secrets that relate
to its materials, manufacturing technology, and applications.
Aeluma is a transformative semiconductor company specializing in high-performance
technology that scales. Applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR, high-performance commuting,
and quantum computing. Aeluma aims to break out of traditional manufacturing to expand the reach of its technology into mass markets.
The demand for higher-performance semiconductors in consumer markets is increasing (https://www.marketsandmarkets.com/Market-Reports/shortwave-ir-market-52975079.html).
Aeluma’s disruptive technology is scalable, cost-effective, while not sacrificing performance.
Additionally, Aeluma’s technology may be
used to manufacture other electronic and optoelectronic devices including lasers, transistors, and solar cells.
Recent Government Contracts
In August 2024, we received a contract by NASA
to develop quantum dot photonic integrated circuits (PICs) on silicon. This advanced technology targets next-generation space and aerospace
applications, enabling capabilities such as free-space laser communication, autonomous navigation, and precision sensing.
In September 2024, we received an $11.7 million contract with
DARPA to develop heterogeneous integration technology for nano-scale semiconductors that is compatible with leading-edge and future advanced-node
semiconductors. Technology applications include AI, mobile devices, and 5G/6G wireless networking. This DARPA contract to Aeluma is structured
with $6.0 million expected to be invoiced over the first 18 months and the remaining $5.7 million invoiced over the following
18 months, contingent on Aeluma meeting certain milestones.
In April 2025, we received a contract with the
U.S. Department of Energy to develop commercially viable, low-cost shortwave infrared (SWIR) photodetectors. The award will accelerate
commercialization of Aeluma’s wafer-scale platform for high-sensitivity, energy-efficient photodetector sensors applicable across
critical growth sectors.
In June 2025, we received a contract with the
U.S. Navy that could accelerate development of high-speed photodetectors for government and commercial applications. The new contract
is for up to $1.3 million in funding, includes a major global interconnect manufacturer as a proposed subcontractor, and involves support
from a top-tier government prime contractor.
In June 2025, we received a contract with the
U.S. Navy that could accelerate development and commercialization for next-generation quantum computing and sensing systems. The new contract
will support Aeluma’s low size, weight, and power imaging sensors for next-generation submarine systems.
Private Placements and Conversion of Notes
Between August 5, 2024 and August 27, 2024, we issued convertible promissory
notes in the aggregate principal amount of $3.1 million to 10 accredited investors, pursuant to a private note financing. The Notes were
to mature in June 2026 and did not carry any interest. The Notes were convertible into shares of the Company’s common stock par
value $0.0001 per share (the “Common Stock”) upon the occurrence of certain events, (i.e., qualified financing resulting in
at least $5.0 million to the Company, if the Common Stock is uplisted to a national securities exchange or if neither of those such events
occur prior to the maturity date, (together with Sale of the Company (as hereinafter defined), a “Conversion Event”)). In
the event the Company did not complete qualified financing or uplist at or before the maturity date, the outstanding balance of the Notes
would automatically convert without any further action by the Holder into shares of the Company’s common stock equal to eighty-five
percent (85%) to the VWAP of the Common Stock on the OTC Markets for the five trading days immediately prior to maturity date. The Note
also provided that if there was a Sale of the Company, as defined in the Note, the Holder may elect to receive a cash payment equal to
the aggregate amount of principal then outstanding under such Holder’s Note or convert the Note into shares of Common Stock equal
to 85% of the VWAP of the Common Stock on the OTC Markets for the five trading days immediately prior to the Sale of the Company. Although
the conversion price was dependent upon the type of Conversion Event that occurs, the Note carried a ceiling and floor price: the applicable
conversion price would not be lower than 85% of the 5-day VWAP on the applicable Closing Date (the “Floor Price”) nor would
the applicable conversion price be higher than $3.50 per share (the “Ceiling Price”); the Floor Price and Ceiling Price shall
automatically adjust in the event of a stock split or consolidation by the Company. The Floor Price for the investors who participated
in this initial closing was equal to $2.68 per share. Since the Floor Price is tied to the Closing Date, the Floor Price may be different
for investors who are part of a different closing, should the Company hold additional closings. The Investors were granted piggyback registration
rights for the shares of Common Stock underlying the Note.
The Note Purchase Agreement (“NPA”)
also contains customary representation and warranties of the Company and the Investors, indemnification obligations of the Company, termination
provisions, and other obligations and rights of the parties.
The foregoing description of the NPA and the Note
is qualified by reference to the full text of the forms of NPA and Note, which are filed as Exhibits hereto and incorporated herein by
reference.
On March 25, 2025, we determined that a Conversion
Event had occurred pursuant to the terms of the Notes. As a result, all holders elected to convert their Notes at the applicable Ceiling
Price of $3.50 per share, resulting in the issuance of an aggregate of 898,573 shares of Common Stock in exchange for $3.1 million in
outstanding principal under the Notes. Following the conversion, we have no further obligations under the converted Notes. The shares
issued upon conversion are subject to piggyback registration rights previously granted to the investors. See Public Offering of Common
Stock in Note 3 – Convertible Notes
Public Offering of Common Stock
On March 26, 2025, we entered into an Underwriting
Agreement (“UA”) with Craig-Hallum Capital Group LLC in connection with a public offering of 2,285,714 shares of its common
stock at a price of $5.25 per share (the “Offering”). We also granted the Underwriter a 30-day option to purchase up to an
additional 342,857 shares to cover over-allotments, which was exercised in full on March 27, 2025. The Offering closed on March 28, 2025.
The Offering was conducted pursuant to our registration
statements on Form S-1 (File No. 333-285469), declared effective by the SEC on March 25, 2025, and on Form S-1MEF filed under Rule 462(b),
effective March 26, 2025.
Under the terms of the UA, we provided a 7.0%
underwriting discount per share and issued to the Underwriter warrants to purchase up to 5.0% of the total shares sold in the Offering
(including the over-allotment shares), with an exercise price equal to 115% of the public offering price.
Total gross proceeds from the Offering, including the over-allotment
option, were $13.8 million. Net proceeds, after underwriting discounts and Offering expenses, were $12.6 million. We intend to use the
proceeds for business development, scaling manufacturing operations, and general corporate purposes.
In connection with the Offering, we, as well as
our directors and officers, agreed to a 90-day lock-up period restricting sales or transfers of Company securities, subject to customary
exceptions. The Underwriter has the discretion to release these restrictions at any time.
Executive Officer Announcements
As of March 18, 2025,
Mr. James Seo agreed to serve as Aeluma’s interim Chief Financial Officer/Principal Accounting Officer until we hire a full-time
CFO. Mr. Seo has been serving as our Controller since May 2023. As of August 4, 2025, Mr. Christopher Stewart agreed to serve as Aeluma’s
Chief Financial Officer/Principal Accounting Officer, replacing Mr. James Seo, our Interim CFO.
Plan of Operations
Our technology is based on heterogeneous integration
of compound semiconductor materials on large-diameter substrates such as silicon. This heterogeneous integration enables the subsequent
device fabrication and manufacturing in large-scale manufacturing environments that are suited to mass markets.
We will continue to develop our technology that
includes novel materials and devices based on our core intellectual property. Our primary focus is to manufacture high-performance semiconductor
technologies that scale for mass markets. Aeluma operates R&D/manufacturing facilities at its headquarters in Goleta, California,
and has developed relationships with volume fabrication foundries and packaging partners. We will continue to mature our manufacturing
processes to further our commercialization traction. We have generated revenue through various customer and government contracts, including
small-volume orders, engineering sample evaluations, non-recurring engineering (NRE) development efforts, and R&D projects. We will
continue to perform on these various efforts, expand our business development and marketing efforts, further engage with our manufacturing
partners, and continue our efforts toward volume production and commercialization. We expect to rely on such external capabilities to
scale our production capacity in support of high-volume markets.
Limited Operating History
We have a limited operating history, and our future
success is subject to numerous uncertainties and risks inherent in the development of a new business. Although we successfully completed
our public offering on March 26, 2025, raising gross proceeds of $13.8 million, there can be no assurance that these funds will be sufficient
to carry out all aspects of our business plan.
FollowingWe thehave Offering,raised managementapproximately has$60 assessedmillion through
ourpublic financialofferings positionfrom March 2025 to date. We have also established an at-the-market offering program to sell up to $50 million of common
stock, pursuant to which we have $29.3 million in remaining capacity. The proceeds of these offerings have been used primarily to fund
R&D efforts, expand engineering capabilities, and operatingsupport plangeneral andcorporate determined that the previously reported substantial doubt about our ability to continue
as a going concern has been alleviated.operations. The proceeds from the Offeringcompleted offerings
have provided near-term capital to support our operations and ongoing
development efforts. However, we continue to face risks typical
of early-stagedevelopment companies,stage includingcompanies including, but not limited capital resources,to, operational
and financial challenges, and uncertainty in product development.development,
and product-market fit.
As of June 30, 2026, the proceeds from these offerings continued to support our working capital, operations, and planned business development activities. Management continues to monitor capital market conditions and may consider other future financing if needed.
Recent Government Customer Contracts
During the fiscal year ended June 30, 2026, we entered into six new government customer contracts, including with NASA, the State University of New York, and the Office of the Secretary of Defense. We also continued to perform under existing customer contracts, including contracts with the U.S. Navy and U.S. Defense Advanced Research Projects Agency, which contributed significantly to our revenue during the year.
Also, as previously announced, we have signed a letter of intent for up to $30 million of proposed funding under the CHIPS Act, which is administered by the U.S. Department of Commerce. The award would support R&D of our scalable, non-InP semiconductor manufacturing platform for photonics, an important technology for the U.S. economy and national security.
The award remains subject to the completion of further due diligence, required approvals, including internal approvals of the U.S. Government, and the parties’ negotiation and execution of definitive award documents. The letter of intent contemplates a portion of the award being funded up front and the remainder funded on a milestone-based award structure tied to eligible project costs and technical progress. In connection with executing final award documents, We would issue equity securities to the U.S. Department of Commerce with an aggregate value equal to the award amount.
Components of Results of Operations
Our results of operations for the fiscal year ended June 30, 2026, as compared to the same period of 2025, were as follows ($ in thousands):
Revenue decreased $204 thousand to $4.5 million, of which $4.3 million was derived from government contracts and $183 thousand from other products and services for the fiscal year ended June 30, 2026. Revenue was $4.7 million, of which $4.4 million was derived from government contracts and $266 thousand from other products and services, for the same period of 2025.
Our revenue currently consists of commercial product
sales and government contracts.
Operating expenses increased $7.8 million, or 115%, to $14.6 million for the fiscal year ended June 30, 2026, compared to $6.8 million for the same period in 2025. The increase was primarily driven by an increase in material purchases to support the delivery of our products and services associated with revenue, as well as higher compensation and related costs, including salaries, stock-based compensation and employee benefits driven by new employees hired to support the expansion of the business and scaling of operations.
Cost of revenue consists of costs of materials,
as well as direct compensation and other expenses incurred to provide deliverables that resulted in payment of our services performed
and wafers delivered. We anticipate that our cost of revenue will vary substantially depending on the nature of products and/or services
delivered in each customer engagement.
R&D expenses consist primarily of compensation
and related costs for personnel, including stock-based compensation and employee benefits, costs associated with design, fabrication,
packaging and testing of our devices, and facility lease and utility expenses. We expense R&D expenses as incurred.
General and administrative expenses consist primarily
of compensation and related costs for personnel, including stock-based compensation and employee benefits. In addition, general and
administrative expenses include third-party consulting, legal, insurance, audit and accounting services, and office lease and utility
expenses.
Other income of $1.0 million for the fiscal year ended June 30, 2026 consisted of interest income, compared to other expense of $880 thousand for the same period of 2025, comprised of amortization of discount on convertible notes of ($715) thousand and changes in fair value of derivative liabilities of ($278) thousand, and interest income of $113 thousand.
Interest income consists primarily of interest
earned in interest-bearing savings accounts and certificates of deposit placed in a bank.
Amortization of discount on convertible notes
represents the non-cash interest expense associated with the amortization of convertible notes issued to our debtholders.
Changes in the fair value of derivative liabilities
reflect valuation changes in the derivatives held by us.
Income tax expense consists primarily of income taxes in certain state
jurisdictions in which we conduct business.
Results of Operations
Our results of operations for the fiscal year
ended June 30, 2025, as compared to the same period of 2024, were as follows ($ in thousands):
Revenue: Revenue increased $3.7 million to $4.7 million, of which $4.4 million
was derived from government contracts and $266 thousand from commercial product and service contracts for the fiscal year ended June 30,
2025. Revenue was $919 thousand, of which $854 thousand was derived from government contracts and $65 thousand from commercial product
and service contracts, for the fiscal year ended June 30, 2024.
Operating expenses: Operating expenses
increased $1.3 million, or 24.2%, to $6.8 million for the fiscal year ended June 30, 2025, compared to $5.5 million for the same period
in 2024. The increase was primarily driven by an increase in material purchases to support the delivery of our products and services associated
with revenue, as well as higher compensation and related costs, including salaries, stock-based compensation and employee benefits.
Other (income) expense: Other (income)
expense consists of amortization of discount on convertible notes of ($715) thousand, changes in fair value of derivative liabilities
of ($278) thousand, and interest income of $113 thousand for the fiscal year ended June 30, 2025.
Income tax expense: No income tax expense was recorded for the
fiscal years ended June
30, 20252026 and 2024.2025.
As of June 30, 2025,2026, we had cash, cash equivalents,
and a certificate
of deposit totaling $15.7$56.0 million, compared to $1.3$15.7 million as of June 30, 2024.2025. The increase in cash was primarily
attributable to the
net proceeds from the Offering,public whichofferings, generatedtotaling gross$43.5 proceedsmillion. These funds are primarily held in cash on deposit and
money market funds that invest 100% of $13.8their million,assets offsetin byshort-term underwritingU.S. discountsTreasury and offering expenses
totaling $1.2 million.obligations.
Prior to the Offering,public offerings, our operations
were primarily
financed through the issuance of convertible notes and sales of common stock in private placement transactions. AsWe previously disclosed,intend
we had expressed substantial doubt about our ability to continue asto ause goingthe concernnet dueproceeds from the offerings to recurringsupport lossesoperational growth, invest in product development, and negativefund operatingworking
capital cash
flows.and Withgeneral thecorporate successful completion of the Offering, we believe that substantial doubt about our ability to continue as a going concern
has been alleviated for at least the next twelve months.purposes.
On March 20, 2026, we entered into a Sales Agreement under which we may, from time to time, offer and sell shares of our common stock, par value $0.0001 per share, for aggregate gross proceeds of up to $50.0 million, through the ATM program. During May and June 2026, we sold 830,484 shares of our common stock under the ATM program, resulting in net proceeds of $20.1 million, after deducting commissions and other offering expenses.
We intend to use the net proceeds from the Offering
to support operational growth, invest in product development, and fund working capital and general corporate purposes. Based on our current
operating plan, we believe that our existing cash, cash equivalents, and certificate of deposit, combined with projected revenues and
cost management strategies, will be sufficient to meet our working capital and capital expenditure requirements for at least the next
twelve months.
What changed in the latest 10-Q
Risk Factors
New heading “Dependence on customers in regulated industries and changes in applicable laws and regulations could adversely affect demand for our products and business.”
Largest changes
“Dependence on customers in regulated industries and changes in applicable laws and regulations could adversely affect demand for our products and business.”see in full comparison
“Our business prospects depend, in part, on the demand for our products from customers operating in industries that are or may be subject to evolving federal, state, local and foreign laws and regulations. …”see in full comparison
Full comparison: every changed paragraph (2)
Dependence on customers in regulated industries and changes in applicable laws and regulations could adversely affect demand for our products and business.
Our business prospects depend, in part, on the demand for our products from customers operating in industries that are or may be subject to evolving federal, state, local and foreign laws and regulations. Changes in, or the interpretation, implementation or enforcement of, such laws and regulations, including those relating to environmental protection, trade policy, export controls, data privacy, taxation, or industry-specific compliance requirements, may increase our customers’ costs of doing business, restrict their operations, delay or cancel their capital expenditure plans, or otherwise adversely affect their financial condition.
Management's Discussion & Analysis (MD&A)
Removed heading “Other Recent Events”
Largest changes
see in full comparisonFollowingTothesupportofferings,thesemanagementactivities,hasweassessedcompleted publicourofferingsfinancialinpositionMarch 2025 andoperatingSeptemberplan2025, raising gross proceeds of $13.8 million anddetermined$25.4thatmillion,therespectively.previouslyThereportedproceedssubstantialhave beendoubtusedabout our abilityprimarily tocontinuefund research and development efforts, expand engineering capabilities, and support general corporate operations.as a going concern has been alleviated.The proceeds from the completed offerings have provided near-term capital to support our operations and ongoing development efforts. However, we continue to face risks typical ofearly-stagedevelopmentcompanies,stageincludingcompanies including, but not limitedcapitalto,resources,operational and financial challenges, uncertainty in productdevelopmentdevelopment, and product-market fit.
Prior to the public offerings, our operations were primarily financed through the issuance of convertible notes and sales of common stock in private placement transactions.see in full comparisonAsWepreviously disclosed,intendwe had expressed substantial doubt about our abilityto continueastoausegoingtheconcernnetdueproceeds from the offerings torecurringsupportlossesoperational growth, invest in product development, andnegativefundoperatingworking capitalcash flows.andWithgeneralthecorporatesuccessful completion of the offerings, we believe that substantial doubt about our ability to continue as a going concern has been alleviated for at least the next twelve months.purposes.
“On March 20, 2026, we entered into a sales agreement, pursuant to which we may, from time to time, offer and sell shares of our common stock, par value $0.0001 per share. The Sales Agreement provides for an aggregate offering amount of up to $50.0 million of our common stock, through an “at-the-market” offering program. Proceeds from the sales will be used for general corporate purposes, including working capital and other liquidity needs.”see in full comparison
“On March 20, 2026, we entered into a Sales Agreement under which we may, from time to time, offer and sell shares of our common stock, par value $0.0001 per share, for aggregate gross proceeds of up to $50.0 million, through an “at-the-market” offering program. Any proceeds, if and when received, are expected to be used for general corporate purposes, including working capital and other liquidity needs.”see in full comparison
“We have a limited operating history and our operations remain in the development stage. To date, our activities have been primarily concentrated on product design, engineering validation, prototyping, and establishing manufacturing and supply chain relationships. We have not yet generated significant revenues from commercial product sales and continue to devote substantial resources to research and development, product qualification, and market readiness.”see in full comparison
Full comparison: every changed paragraph (25)
During the quarterthree and nine months ended DecemberMarch 31, 2025,
2026, we
did not enterentered into anyfour and five new material government contracts.contracts, respectively, that include NASA, the State University of New York,
and the Office of the Secretary of Defense. We also continue to perform under existing contracts, including contracts with NASA,
the U.S. Navy,
the U.S. Department of Energy, and U.S. Defense Advanced Research Projects Agency, which remain significant sources of
revenue.
We completed two underwritten public offerings
of our common stock, raising net proceeds of $12.6 million in March 2025 and $23.4 million in September 2025. As of DecemberMarch 31, 2025,2026, the
the proceeds from these offerings continue to support our working capital, operations, and planned business development activities. No
additional equity offerings are planned at this time, but management continues to monitor capital market conditions and may consider future
financing if needed.
On March 20, 2026, we entered into a sales agreement, pursuant to which we may sell shares of our common stock having an aggregate offering price of up to $50 million, through an “at-the-market” offering program. As of March 31, 2026, no sales of our common stock were transacted under this agreement. We are not obligated to sell, and the agents are not obligated to buy or sell, any shares under the agreement. Any shares will be offered and sold under the agreement will be pursuant to the Company’s effective shelf registration statement on Form S-3.
Management continues to monitor capital market conditions and may consider other future financing if needed.
Other Recent Events
On August 4, 2025, we appointed Christopher Stewart
as our Chief Financial Officer. Pursuant to Mr. Stewart’s employment agreement, he was granted 110,000 stock options and 55,000 restricted
stock units (“RSUs”). The stock options have an exercise price of $21.04, with 25% of the stock options vesting on the
twelve (12) month anniversary of Mr. Stewart’s employment with the Company. The balance of the stock options will vest in equal
monthly increments on each monthly anniversary of Mr. Stewart’s employment start date with the Company, over the next thirty-six
(36) months. The stock options expire on the 10-year anniversary of their vesting date. 25% of the shares underlying the RSUs will
vest at the end of the fiscal quarter following the twelve (12) month anniversary of Mr. Stewart’s employment start date with the
Company, with a pro-rated amount for any partial quarter preceding the twelve (12) month anniversary. The remaining RSUs will vest in
equal quarterly increments, with a pro-rated amount for any partial final quarter. Each restricted stock unit represents the contingent
right to receive, at settlement, one share of common stock.
We have a limited operating history and our operations remain in the development stage. To date, our activities have been primarily concentrated on product design, engineering validation, prototyping, and establishing manufacturing and supply chain relationships. We have not yet generated significant revenues from commercial product sales and continue to devote substantial resources to research and development, product qualification, and market readiness.
We have a limited operating history, and our future
success is subject to numerous uncertainties and risks inherent in the development of a new business. Although we raised substantial funds
through underwritten completed public offerings in March 2025 and September 2025, raising gross proceeds of $13.8 million and $25.4 million,
respectively, there can be no assurance that these funds will be sufficient to carry out all aspects of our business plan.
FollowingTo thesupport offerings,these managementactivities, haswe assessedcompleted public
ourofferings financialin positionMarch 2025 and operatingSeptember plan2025, raising gross proceeds of $13.8 million and determined$25.4 thatmillion, therespectively. previouslyThe reportedproceeds substantialhave
been doubtused about our abilityprimarily to continuefund research and development efforts, expand engineering capabilities, and support general corporate operations.
as a going concern has been alleviated. The proceeds from the completed offerings have provided near-term capital to support our operations and
ongoing development efforts. However,
we continue to face risks typical of early-stagedevelopment companies,stage includingcompanies including, but not limited capitalto, resources,
operational and financial challenges,
uncertainty in product developmentdevelopment, and product-market fit.
On March 20, 2026, we entered into a sales agreement, pursuant to which we may, from time to time, offer and sell shares of our common stock, par value $0.0001 per share. The Sales Agreement provides for an aggregate offering amount of up to $50.0 million of our common stock, through an “at-the-market” offering program. Proceeds from the sales will be used for general corporate purposes, including working capital and other liquidity needs.
Interest income consists primarily of interest
earned in interest-bearing savings accounts andaccounts, certificates of deposit held at a bank.bank, and money market funds that invest 100% of their
assets in short-term U.S. Treasury obligations.
Our results of operations for the sixnine months
ended ended
DecemberMarch 31, 2025,2026, as compared to the same period of 2024,2025, were as follows ($ in thousands):
Revenue: Revenue increased $564$531 thousand
to $2.7$3.9 million, of which $2.6$3.8 million was derived from government contracts and $41 thousand from other products and services for the
sixnine months ended DecemberMarch 31, 2025.2026. Revenue was $2.1$3.3 million, of which $1.9$3.1 million was derived from government contracts and $201 thousand
from other products and services, for the same period of 2024.2025.
Operating expenses: Operating expenses
increased $3.9$5.2 million, or 160.7%,114%, to $6.3$9.7 million for the sixnine months ended DecemberMarch 31, 2025,2026, compared to $2.4$4.5 million for the same period
in 2024.2025. The increase was primarily driven by an increase in material purchases to support the delivery of our products and services associated
with revenue, as well as higher compensation and related costs, including salaries, stock-based compensation and employee benefits driven
by new employees hired to support the expansion of the business and scaling of operations.
Other income (expense): Other income (expense)of
consists of interest income of $343$668 thousand for the sixnine months ended DecemberMarch 31, 2025,2026 consisted of interest income, compared to other ($3.3expense) millionof $990 thousand for
the same period of 2025, comprised of amortization
of discount on convertible notes of ($428$715) thousand and changes in fair value of derivative
liabilities of $($2.9279) millionthousand, forand theinterest same
periodincome of 2024.$3 thousand.
Income tax expense: No income tax expense
was recorded for the sixnine months ended DecemberMarch 31, 20252026 and 2024.2025.
As of DecemberMarch 31, 2025,2026, we had cash, cash equivalents,
and a certificate of deposit totaling $38.6$37.8 million, compared to $15.7 million as of June 30, 2025. The increase in cash was primarily
attributable to net proceeds from the public offerings, totaling $23.4 million. These funds are primarily held in cash on deposit and
money market funds that invest 100% of their assets in short-term U.S. Treasury obligations.
Prior to the public offerings, our operations
were primarily
financed through the issuance of convertible notes and sales of common stock in private placement transactions. AsWe previously disclosed,intend
we had expressed substantial doubt about our ability to continue asto ause goingthe concernnet dueproceeds from the offerings to recurringsupport lossesoperational growth, invest in product development, and negativefund operatingworking
capital cash
flows.and Withgeneral thecorporate successful completion of the offerings, we believe that substantial doubt about our ability to continue as a going concern
has been alleviated for at least the next twelve months.purposes.
On March 20, 2026, we entered into a Sales Agreement under which we may, from time to time, offer and sell shares of our common stock, par value $0.0001 per share, for aggregate gross proceeds of up to $50.0 million, through an “at-the-market” offering program. Any proceeds, if and when received, are expected to be used for general corporate purposes, including working capital and other liquidity needs.
We intend to continue to use the net proceeds
from the offerings to support operational growth, invest in product development, and fund working capital and general corporate purposes.
Based on our current operating plan, we believe that our existing cash, cash equivalents, and certificate of deposit, combined with projected
revenues and cost management strategies, will be sufficient to meet our working capital and capital expenditure requirements for at least
the next twelve months.
We will continue to assess our capital requirements
and may pursue additional financing opportunities to support long-term growth initiatives or respond to changes in market conditions.
As of DecemberMarch 31, 2025,2026, we had net working capital,
defined as total current assets less total current liabilities, of $39.4$38.6 million, compared to $16.6 million at June 30, 2025. The increase
was primarily driven by a $22.9$22.8 million increase in current assets, which rose to $40.3$40.2 million from $17.3 million over the same period,
largely due to a $22.8$22.0 million increase in cash and cash equivalents.equivalents, including the certificate of deposit balance at June 30, 2025.
Current liabilities totaled $825$1.5 thousandmillion and $705 thousand as of
December March 31, 20252026 and June 30, 2025, respectively, and the balances primarily
consisted of accounts payable, along with accrued expenses
and other short-term obligations expected to be settled within one year.
Net cash used in our operating activities was
$1.1$1.6 million and $1.3$1.1 million for the sixnine months ended DecemberMarch 31, 20252026 and 2024,2025, respectively. For the sixnine months ended DecemberMarch 31, 2026,
2025, the net cash used in operating activities primarily resulted from a net loss of $3.3$5.1 million and decreasesa decrease in accountsprepaids payableand other current
assets of
$177 $699 thousand, primarily offset by non-cash stock-based compensation expense of $2.1$3.2 million and depreciationan andincrease amortizationin expenseaccounts payable
of $210$612 thousand. For the sixnine months ended DecemberMarch 31, 2024,2025, the net cash used in operating activities was primarily attributable to a
a net loss of $3.6$2.2 million,million increasesand a decrease in accounts receivable of $1.3$1.1 million and prepaid and other current assets of $115 thousand, and
a decrease in accounts payable of $134 thousand.million. These amounts were partially offset by non-cash expenses expenses,
including changesstock-based incompensation fair value
of derivative liabilitiesexpense of $2.9$1.1 million, amortization of discount on convertible notes of $428$715 thousand, stock-based compensation expensedepreciation
of $316 thousand, and depreciation and amortization expense of $202$307 thousand, and changes in fair value of derivative liabilities of $278 thousand.
Net cash used in our investing activities totaled
$241$439 thousand and $41$85 thousand for the sixnine months ended DecemberMarch 31, 20252026 and 2024,2025, respectively. These investing activities primarily consisted
consisted of purchases of equipment.
Net cash provided by our financing activities
was $24.1 million for the sixnine months ended DecemberMarch 31, 2025,2026, compared to net cash provided by our financing activities of $3.1$15.7 million
for the same period in 2024.2025. WeFor the nine months
ended March 31, 2026, we received $23.4 million, net of offering costs, from the public offering, $690 thousand from the exercise
of stock warrants
warrants, and $64$103 thousand from the exercise of stock optionsoptions. forFor the sixnine months ended DecemberMarch 31,1, 2025, comparedwe toreceived $12.6 million, net
of offering costs, from the public offering and $3.1 million
from the issuance of convertible notes during the same period in 2024.notes.
ALMU insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 8 filings (2 insiders, 9 trade dates, 255,000 shares, about $4.3M; 7 of these filings say the sales were made under a Rule 10b5-1 trading plan). Net open-market shares: -255,000 (purchases minus sales); net value about -$4.3M.Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
| Trade date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-30 | Stewart Christopher P. |
Shares withheld for tax | 5,697 | $12.36 | $70.4K |
| 2026-09-21 | Stewart Christopher P. |
Grant/award | 4,042 | — | — |
| 2026-09-21 | Stewart Christopher P. |
Grant/award | 15,886 | — | — |
| 2026-09-21 | Stewart Christopher P. |
Shares withheld for tax | 1,450 | $13.61 | $19.7K |
| 2026-09-21 | Klamkin Jonathan |
Shares withheld for tax |
4,547 | $13.61 | $61.9K |
| 2026-09-21 | Klamkin Jonathan |
Open-market sale |
100,000 | $13.35 | $1.3M |
| 2026-09-21 | Klamkin Jonathan |
Grant/award |
12,675 | — | — |
| 2026-09-21 | Klamkin Jonathan |
Grant/award |
31,771 | — | — |
| 2026-09-21 | Byron Michael |
Option exercise | 25,000 | $5.93 | $148.2K |
| 2026-08-27 | Denbaars Steven |
Open-market sale |
12,500 | $13.82 | $172.8K |
| 2026-08-27 | Denbaars Steven |
Open-market sale | 12,500 | $13.82 | $172.8K |
| 2026-08-26 | Denbaars Steven |
Open-market sale |
12,500 | $13.84 | $173.0K |
| 2026-08-26 | Denbaars Steven |
Open-market sale | 12,500 | $13.84 | $173.0K |
| 2026-08-03 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-08-03 | Klamkin Jonathan |
Open-market sale |
15,810 | $16.85 | $266.4K |
| 2026-08-03 | Klamkin Jonathan |
Open-market sale |
4,190 | $16.29 | $68.3K |
| 2026-08-03 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-07-01 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-07-01 | Klamkin Jonathan |
Open-market sale |
100 | $21.56 | $2.2K |
| 2026-07-01 | Klamkin Jonathan |
Open-market sale |
19,900 | $21.08 | $419.5K |
| 2026-07-01 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-06-01 | Klamkin Jonathan |
Open-market sale |
1,400 | $23.32 | $32.6K |
| 2026-06-01 | Klamkin Jonathan |
Open-market sale |
8,200 | $26.25 | $215.2K |
| 2026-06-01 | Klamkin Jonathan |
Open-market sale |
1,600 | $25.12 | $40.2K |
| 2026-06-01 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-06-01 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-06-01 | Klamkin Jonathan |
Open-market sale |
900 | $22.19 | $20.0K |
| 2026-06-01 | Klamkin Jonathan |
Open-market sale |
7,900 | $24.39 | $192.7K |
| 2026-05-20 | Denbaars Steven |
Open-market sale |
942 | $21.30 | $20.1K |
| 2026-05-20 | Denbaars Steven |
Open-market sale |
11,558 | $20.40 | $235.8K |
| 2026-05-19 | Denbaars Steven |
Open-market sale |
7,415 | $19.56 | $145.0K |
| 2026-05-19 | Denbaars Steven |
Open-market sale |
5,085 | $20.61 | $104.8K |
| 2026-05-01 | Klamkin Jonathan |
Open-market sale |
676 | $25.71 | $17.4K |
| 2026-05-01 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-05-01 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-05-01 | Klamkin Jonathan |
Open-market sale |
4,300 | $24.20 | $104.1K |
| 2026-05-01 | Klamkin Jonathan |
Open-market sale |
15,024 | $25.15 | $377.9K |
| 2026-04-01 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-04-01 | Klamkin Jonathan |
Gift |
20,000 | — | — |
| 2026-03-04 | Klamkin Jonathan |
Gift |
50,000 | — | — |
| 2026-03-04 | Klamkin Jonathan |
Gift |
50,000 | — | — |
| 2025-12-29 | Klamkin Jonathan |
Gift |
1,126,995 | — | — |
| 2025-12-29 | Klamkin Jonathan |
Gift |
1,126,995 | — | — |
| 2025-12-19 | Klamkin Jonathan |
Gift |
350,000 | — | — |
| 2025-12-19 | Klamkin Jonathan |
Gift |
350,000 | — | — |
Well-known investors holding ALMU (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| D. E. Shaw & Co. | 2026-06-30 | 797,983 | $17.6M | 0.01% | Added 3092% |
| Millennium Management (Israel Englander) | 2026-06-30 | 529,005 | $11.7M | 0.01% | Added 33% |
| Citadel Advisors (Ken Griffin) | 2026-06-30 | 41,219 | $910.1K | 0.0% | New position |